Cargando…
Aspirin Resistance in Vascular Disease: A Review Highlighting the Critical Need for Improved Point-of-Care Testing and Personalized Therapy
Aspirin resistance describes a phenomenon where patients receiving aspirin therapy do not respond favorably to treatment, and is categorized by continued incidence of adverse cardiovascular events and/or the lack of reduced platelet reactivity. Studies demonstrate that one in four patients with vasc...
Autores principales: | Khan, Hamzah, Kanny, Omar, Syed, Muzammil H., Qadura, Mohammad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570127/ https://www.ncbi.nlm.nih.gov/pubmed/36232618 http://dx.doi.org/10.3390/ijms231911317 |
Ejemplares similares
-
Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients)
por: Khan, Hamzah, et al.
Publicado: (2021) -
Low-dose aspirin and rivaroxaban combination therapy to overcome aspirin non-sensitivity in patients with vascular disease
por: Khan, Hamzah, et al.
Publicado: (2022) -
Personalization of Aspirin Therapy Ex Vivo in Patients with Atherosclerosis Using Light Transmission Aggregometry
por: Khan, Hamzah, et al.
Publicado: (2020) -
Plateletworks(®) as a Point-of-Care Test for ASA Non-Sensitivity
por: Khan, Hamzah, et al.
Publicado: (2021) -
The Role of Fatty Acid Binding Protein 3 in Cardiovascular Diseases
por: Li, Ben, et al.
Publicado: (2022)